Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ribosomal protein L26 pseudogene 6 (RPL26P6) is a human pseudogene located on chromosome 10q22.2, identified as a non-functional, processed copy of the gene encoding ribosomal protein L26. As a pseudogene, RPL26P6 does not produce a functional protein product and is not known to play a direct biological role or serve as a therapeutic target. It is one of multiple processed pseudogenes related to the functional ribosomal protein L26 gene, which encodes a structural component of the large (60S) subunit of the cytoplasmic ribosome. The functional RPL26 gene is involved in ribosome assembly, protein synthesis, and has been linked to certain diseases such as Diamond-Blackfan anemia, but RPL26P6 itself lacks such functions or clinical relevance[2][4][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein L26 pseudogene 6 (RPL26P6).